By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Leidos Biomedical Research (Formerly Known As SAIC-Frederick, Inc.) 

Frederick National Laboratory for Cancer Research
P.O. Box B, 8560 Progress Drive
Frederick  Maryland  21702  U.S.A.
Phone: 301-846-1000 Fax: n/a


Leidos Biomedical Research, Inc. operates the Frederick National Laboratory for Cancer Research under contract to the National Cancer Institute, National Institutes of Health, U.S. Department of Health and Human Services.

The national lab partners with university, corporate, and government scientists to accelerate research discoveries, develop new technologies, and move new diagnostics and treatments into the clinic to benefit patients with cancer and AIDS.

As a Federally Funded Research and Development Center, the national lab excels at innovation and flexibility of operations, offering scientific depth, cutting-edge technologies, and enabling infrastructure. It is one of about 40 U.S. national laboratories and the only one in the nation devoted exclusively to biomedical research.

View jobs from this company:

Key Statistics

Ownership: Public

Web Site: Leidos Biomedical Research
Employees: 1850
Symbol: LDOS


Company News
James Bahel Named Leidos Biomedical Research (SAI) Vice President Of Business Development 9/29/2014 10:03:28 AM
SAIC-Frederick, Inc. (SAI) Announces Recent Contract Awards in Healthcare 11/8/2012 12:34:55 PM
PositiveID (PSID) Announces Teaming Agreement With SAIC-Frederick, Inc. (SAI) to Pursue Defense Threat Reduction Agency Contracts 11/6/2012 9:26:44 AM
SAIC-Frederick, Inc. (SAI) Awarded Contract By eHealth Saskatchewan 8/24/2012 11:07:21 AM
SAIC-Frederick, Inc. (SAI)'s $473 Million Aquisition to More than Double Commercial Health Care Business 7/19/2012 7:40:33 AM
SAIC-Frederick, Inc. (SAI) and RemedyMD, Inc. Collaborate to Enhance Research Management Systems in Support of Cancer Research 8/23/2011 12:15:35 PM
ApoCell, Inc. Awarded $2.9 Million from SAIC-Frederick, Inc. (SAI) to Deliver a New Platform for Detection and Molecular Analysis of Circulating Tumor Cells (CTCs) to the National Cancer Institute’s Pharmacodynamics Program 8/10/2011 10:31:50 AM
SAIC-Frederick, Inc. (SAI) Awarded $61 Million Contract by US Army Medical Research and Materiel Command 6/20/2011 7:22:15 AM
SAIC-Frederick, Inc. (SAI) and Biomatrica Collaborate to Improve Molecular Analysis in Cancer Research 5/31/2011 9:30:58 AM
Dr. David Heimbrook Appointed Chief Executive Officer of SAIC-Frederick, Inc. (SAI) 5/25/2011 7:03:00 AM